This year, the vast majority of assays the Belgian company facilitates will be non-invasive prenatal testing, which it only started offering in 2013.
Under the Color Family Testing Program, family members of patients who tested positive for a gene on Color's hereditary cancer test can be tested for $50.
Backed by $12 million from a recent Series A financing and a strategic partnership with Thermo Fisher Scientific, the Ann Arbor, Michigan-based firm plans to sequence the tumors of 100,000 advanced cancer patients over three years.
In a complaint filed yesterday, Foundation claims that the Guardant360 test infringes its US Patent No. 9,340,830.
The company reported 8,985 clinical tests in the first quarter, a 14 percent year-over-year increase.
Over the last half year, CeGaT lowered turnaround times and prices for its assays, and its lab recently passed CAP inspection.
A year after launching the test in the US, the company is making it available in more than 100 countries, partnering with distributors in Israel, Turkey, and Finland.
Kailos will provide lower-cost screening for hereditary ovarian and peritoneal cancers through Teal It's Gone, a non-profit promoting testing options.
In an editorial, Johns Hopkins University's Jennifer Axilbund argues that gene panel testing should be approached with caution.
$12 million of Q4 revenues derived from clinical testing, up 17 percent from $10.3 million a year ago, and $14.1 million from pharmaceutical customers, a 68-percent year-over-year increase.
A genetic genealogy analysis helped secure the release of a California man from prison after getting his murder conviction overturned, the Guardian reports.
Technology Review discusses the concerns that come along with the ability to quickly synthesize viruses like SARS-CoV-2.
Researchers have uncovered large bacteriophages whose genomes include translational machinery, Live Science reports.
In PNAS this week: role for Myc in alternative splicing regulation in prostate cancer, variation in methylation in Arabidopsis, and more.